Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?

Aspirin inhibits the enzyme cyclooxygenase (Cox), and there is a significant body of epidemiological evidence demonstrating that regular aspirin use is associated with a decreased incidence of developing cancer. Interest focussed on selective Cox-2 inhibitors both as cancer prevention agents and as...

Descripción completa

Detalles Bibliográficos
Autores principales: Langley, R E, Burdett, S, Tierney, J F, Cafferty, F, Parmar, M K B, Venning, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208483/
https://www.ncbi.nlm.nih.gov/pubmed/21847126
http://dx.doi.org/10.1038/bjc.2011.289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208483/
https://www.ncbi.nlm.nih.gov/pubmed/21847126
http://dx.doi.org/10.1038/bjc.2011.289

Ejemplares similares